An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

While these advanced imaging tools save lives by detecting injuries and illness, mounting evidence suggests they may come with long-term consequences that patients need to understand before agreeing ...

CT scans identified cancer in 13% of patients with non-specific symptoms, despite a fivefold increase in referrals from GPs from 2012 to 2019. Around 1 in 7 patients were diagnosed with cancer. This ...

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of ...

IN the fight against prostate cancer, one biomarker is proving to be a game changer. According to Sunway Medical Centre Clinical Head and Nuclear Medicine Physician Associate Professor Dr Tan Teik Hin ...